These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32485169)

  • 1. Analytical and clinical characterization of a novel high-sensitivity cardiac troponin assay in a United States population.
    Christenson RH; Duh SH; Mullins KE; LeClair MM; Grigorov IL; Peacock WF
    Clin Biochem; 2020 Sep; 83():28-36. PubMed ID: 32485169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivotal findings for a high-sensitivity cardiac troponin assay: Results of the HIGH-US study.
    Christenson RH; Duh SH; Apple FA; Nowak R; Peacock WF; Limkakeng AT; Bostanian Z; Mohammad A; McCord J; deFilippi CR
    Clin Biochem; 2020 Apr; 78():32-39. PubMed ID: 31669511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the new Beckman Coulter Access hsTnI: 99th percentile upper reference limits according to age and sex in the Korean population.
    Kim S; Yoo SJ; Kim J
    Clin Biochem; 2020 May; 79():48-53. PubMed ID: 32059836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction.
    Keller T; Zeller T; Ojeda F; Tzikas S; Lillpopp L; Sinning C; Wild P; Genth-Zotz S; Warnholtz A; Giannitsis E; Möckel M; Bickel C; Peetz D; Lackner K; Baldus S; Münzel T; Blankenberg S
    JAMA; 2011 Dec; 306(24):2684-93. PubMed ID: 22203537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study.
    Christenson RH; Peacock WF; Apple FS; Limkakeng AT; Nowak RM; McCord J; deFilippi CR
    Contemp Clin Trials Commun; 2019 Jun; 14():100337. PubMed ID: 30834354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation.
    Peacock WF; Christenson R; Diercks DB; Fromm C; Headden GF; Hogan CJ; Kulstad EB; LoVecchio F; Nowak RM; Schrock JW; Singer AJ; Storrow AB; Straseski J; Wu AHB; Zelinski DP
    Acad Emerg Med; 2020 Aug; 27(8):671-680. PubMed ID: 32220124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single test rule-out of acute myocardial infarction using the limit of detection of a new high-sensitivity troponin I assay.
    Body R; Morris N; Collinson P
    Clin Biochem; 2020 Apr; 78():4-9. PubMed ID: 32135083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the analytical and clinical performance of a new high-sensitivity cardiac troponin I assay: hs-cTnI (CLIA) assay.
    Li L; Shu X; Zhang L; Xu A; Yang J; Jing Y; Wang H; Zhang Z
    Clin Chem Lab Med; 2024 Jan; 62(2):353-360. PubMed ID: 37746851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of presentation and 4-hour high sensitivity troponin I to rule-out acute myocardial infarction in the emergency department.
    Pickering JW; Young JM; George P; Aldous S; Cullen L; Greenslade JH; Richards AM; Troughton R; Ardagh M; Frampton CM; Than MP
    Clin Biochem; 2015 Dec; 48(18):1219-24. PubMed ID: 26232285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point-of-Care: Roadmap for Analytical Characterization and Validation of a High-Sensitivity Cardiac Troponin I Assay in Plasma and Whole Blood Matrices.
    Christenson RH; Frenk LDS; de Graaf HJ; van Domburg TSY; Wijnands FPG; Foolen HWJ; Kemper DWM; Bruinen AL; Meijering BDM; Fonville JM; de Theije FK
    J Appl Lab Med; 2022 Jun; 7(4):971-988. PubMed ID: 35660917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction.
    Pickering JW; Greenslade JH; Cullen L; Flaws D; Parsonage W; George P; Worster A; Kavsak PA; Than MP
    Heart; 2016 Aug; 102(16):1270-8. PubMed ID: 26955848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Access hsTnI 99th percentiles upper reference limits following IFCC recommendations.
    Di Pietro M; Dipalo M; Rocchi MBL; Musa R; Avanzini P; Gnocchi C; Anelli MC; Aloe R
    Clin Chim Acta; 2019 May; 492():26-28. PubMed ID: 30711523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay.
    Christenson RH; Mullins K; Duh SH
    Clin Biochem; 2018 Jun; 56():4-10. PubMed ID: 29750939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial.
    Shah ASV; Anand A; Strachan FE; Ferry AV; Lee KK; Chapman AR; Sandeman D; Stables CL; Adamson PD; Andrews JPM; Anwar MS; Hung J; Moss AJ; O'Brien R; Berry C; Findlay I; Walker S; Cruickshank A; Reid A; Gray A; Collinson PO; Apple FS; McAllister DA; Maguire D; Fox KAA; Newby DE; Tuck C; Harkess R; Parker RA; Keerie C; Weir CJ; Mills NL;
    Lancet; 2018 Sep; 392(10151):919-928. PubMed ID: 30170853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance and clinical decision limit of a new release for cardiac troponin I assay.
    Moretti M; Pieretti B; Sisti D; Rocchi M; Gasperoni S
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):169-72. PubMed ID: 24711561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal presenting levels of high-sensitivity troponin and myocardial infarction.
    Hoeller R; Rubini Giménez M; Reichlin T; Twerenbold R; Zellweger C; Moehring B; Wildi K; Freese M; Stelzig C; Hartmann B; Stoll M; Mosimann T; Reiter M; Haaf P; Mueller M; Meller B; Hochgruber T; Balmelli C; Sou SM; Murray K; Freidank H; Steuer S; Minners J; Osswald S; Mueller C
    Heart; 2013 Nov; 99(21):1567-72. PubMed ID: 23604180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rational Adoption of the High Sensitive Assay for Cardiac Troponin I in Diagnostic Routine.
    Croce A; Brunati P; Colzani C; Terramocci R; Favero S; Bordoni G; Galli C
    Dis Markers; 2017; 2017():4523096. PubMed ID: 28588346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of Ortho Clinical Diagnostics high-sensitivity cardiac Troponin I assay in patients with symptoms suggestive of acute coronary syndrome.
    Kavsak PA; Mondoux SE; Sherbino J; Ma J; Clayton N; Hill SA; McQueen M; Mehta SR; Griffith LE; Devereaux PJ; Worster A
    Clin Biochem; 2020 Jun; 80():48-51. PubMed ID: 32304695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay.
    Apple FS; Schulz K; Schmidt CW; van Domburg TSY; Fonville JM; de Theije FK
    Clin Chem Lab Med; 2021 Aug; 59(9):1574-1578. PubMed ID: 34022125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison of clinical decision limits for cardiac troponin T and I.
    Kimenai DM; Henry RM; van der Kallen CJ; Dagnelie PC; Schram MT; Stehouwer CD; van Suijlen JD; Niens M; Bekers O; Sep SJ; Schaper NC; van Dieijen-Visser MP; Meex SJ
    Heart; 2016 Apr; 102(8):610-6. PubMed ID: 26794233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.